PharmaShots | Incisive News in 3 Shots

Subscribe Now

NKGen Biotech

NKGen Biotech Reports First Patient Dosing with SNK01 in P-I/IIa Study for Treating Moderate Alzheimer’s Disease

NKGen Biotech Reports First Patient Dosing with SNK01 in P-I/IIa Study for Treating Moderate Alzheimer’s Disease

December 29, 2023

NKGen Biotech Collaborated with the Parkinson’s Foundation for Novel Natural Killer Cell Therapy to Treat Advanced Parkinson’s Disease

NKGen Biotech Collaborated with the Parkinson’s Foundation for Novel Natural Killer Cell Therapy to Treat Advanced Parkinson’s Dis...

November 7, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us